InstituteOfScience.com

ROSENOW - SUBJECTS

GO TO REFERENCE LIST

--acid intoxication action of pneumococcus 05R1-872
--acidity-alkalinity of urine 05R1-872
--acidity, effects on phagocytosis (reduced) 07R1-288
--administration of vaccine and antibody (for MS) - 57R1
-- aerial infection plays minor role in epidemics 50R3-292
-- agglutination tests, various diseases 42R2-352
--agglutinins, production of, with heat and H2O2 47R1-221, 229
--Air (outdoor), production of streptococcus from - 51R2
-- air, seasonally virulent streptococci in 50R1-122
--alkalinity-acidity of urine 05R1-872
--alkalinity and ulcer therapy: local or systemic action? 16R8-357
--alkaline therapy 05R1-872
--allergy to streptococci as may relate to disease 42R2-353
--allergy: acquired immunity associated w/anaphylaxis 08R3-643
--animal studies, involving 2000 animals 18R3-341
--anthrax protein, hypersuscept. doesn't confer immunity 08R3-643
--antibody administration - subcutaneous or IM - 52R1-400, 52R3-309
--antibody globulin weight as mostly globulin 47R1-231
--antibody globulin from diffusible antibody, globulin 47R1-231
--vaccine preparation, administration, for colds, influenza
--Beneficial results - 38R2-20
--Vaccine prep. summary - 55R2, 38R2-19
--Vaccine prep. detail, etc - 1934 (Colds/Influenza)- 34R3-408
--antibody produced by "oxidative reactions" 47R1
--antiseptics in root canals, failings 34R5-724
--Artificial antibody production: 45R4, 47R1, 48R5, 55R1
--artificial mediums, folly of long cultivation on 34R3-431
--atmospheric influence on seasonality of epidemics 50R1-122
--autogenous sensitizing strepto.-nerve-tissue complex 48R3-291
--autogenous vaccine, advantage 15R11-260
--autogenous vaccine preparation 37R1-255; 39R1-36-7
--autoimmunity as possibly involved in MS 48R3-291-2

GO TO REFERENCE LIST

--bacillus aerogenes, serial dilution cultures 38R5
--bacillus coli, serial dilution cultures 38R5
--Bacillus Friedlander A & B, serial dilution cultures 38R5
--bacillus subtilis, serial dilution cultures 38R5
--bacteria at pulpless tooth apex not encapsulated 40R3-265
--bacteria grown from bacteria-free & phage-lysed cultures 38R5-76
--bacterial growth at very high dilutions, e.g. 10-20 38R5-71,76
--Barber method of assuring single organism 14R4-29
--becoming of age at Mayo 52R2-244
--blood culture methodology 48R1
--blood, organism in, in various diseases 05R1, 14R12, 15R10, 15R3, 16R8, 33R7, 45R2, 47R2, 48R2, 48R5
--blood, antigen in, of patients w/active focal infection 37R1-253
--blood, antigen in (encephalitic) blood of horses 37R5-825
--bloodstream, importance as carrier of infection 15R10-403

GO TO REFERENCE LIST

--capsule absent from bacteria at pulpless tooth apex 40R3-265
--carnivores as host for B. welchii; vs. herbivores 14R12-906
--cataphoretic mobility of 5000 cultures measured 30R1-49-50
--Cataphoretic potential: 30R1, 30R2, 34R5, 35R4, 35R6, 36R1
--cataphoretic potential and elective localization 30R6,33R7
--cataphoretic studies with Jensen, president Ill.M.A. 39R1-33
--cataphoretic time as alternative to use of animals 40R3-274
--cataphoretic velocities, by diseases 34R2-93-4, 111-13
--cataphoresis technic; cataphoretic velocities 33R6-2
--causative organism from blood and tissues in many diseases -14R12
--causative streptococcus: modifications of one strain? 30R6-58
--cell-wall-deficient bacteria at pulpless tooth apex 40R3-265
--change in virulence in chick embryo medium - 50R1
--chick embryo medium favors growth & maint. of strepto. 50R1-117
--chick embryo medium - recipe 50R1-117
--chick cultures change seasonally w/epidemics 50R1-117
-- chick culture begets filtrable agent from streptococcus 44R6
-- chick-mash formula 35R5-410
--chronic cases, need for prolonged vaccine-therapy in 33R3- 183
--confirming studies using Rosenow's methods, list of 15 48R1-125
--constitutional predisposition and invading organism 40R3-273
--contact infection plays minor role in epidemics 50R3-292
--culture methodology, medium; etc. 38R5,44R1-151
--cutaneous reactions, diverse diseases 58R1-756
--cutaneous reactivity of thermal antibody vs natural 45R2-148

GO TO REFERENCE LIST

--danger of removing multiple foci at one time, fatality 19R6-218
--danger of intravenous injection of antigen 16R1-1929
--dental caries and modernization -40R3-260 (W.Price in)
-- desensitizing action in small vaccine doses like pollen 39R1-32
--detoxifying effect of glycerin and salt on streptococci 34R3-407
--devitalization/root canal therapy should cease 30R6-56,34R5-740
--devitalized teeth, Meisser's dog experiments 34R5-724
-- dextrose-brain broth, importance to preserve strain 34R5-738
--dextrose-brain broth, method of culture 42R2-348-9
--Diagnostic cutaneous reactions: 48R5
--diet, ill effect of foci on otherwise-sufficient 34R5-733
--different diseases, same bacteria 16R7-662
--different forms of diseases, explanation of 15R9-1691
-- diffusible antibody from enzymatic action of antigen 47R1-231
--Diptheroid bacteria & elective localiz. etc.: 15R1
--diptheroid bacillus resembles streptococci in some stages 15R4
--direct inoculation of animals w/nasopharyngeal swabbing 33R6-1
--diseases in which bacteria were found to electively localize 39R1
--diverse specificities of streptococci acquired in hosts 58R1-760
--dosage: considerations; keep small-28R10-234, 37R1-256, 29R1-511
--dose, prophylactic vaccine inoculation 34R3-408
--drugs, chemicals, toxins: streptococcal localization likened to 48R1-125, 39R1-31, 52R1-398

GO TO REFERENCE LIST

--effect of antibody and/or histamine on skin reactions 48R3- 283
--electric charge vs disease type 37R1-253-4
--elective localization and focal infection: see "focal infection and elective localization"
--Encyclopedia Brit., Rosenow on "Focal Infection" 28R7-433
--epidemic: strep.normally in throat acquire specific property 24R7
--erythematous reactions to antigen/antibody 48R2-367, 42R2- 347
--essential components of methodology: 53R2, 58R1
---dextrose-brain-broth medium - 34R3, 34R5-738; 50R1
---glycerine-salt mentsruum - 52R3-306, 38R2
---serial dilution method - 55R1, 51R4-616
--etiological importance of non-vital or diseased teeth - 40R3,44R8
--etiologic role of streptococcus 18R3-340
--etiology, proof is reproduction in animals 53R1-415
--etiology, summary of six types of evidence of 40R3- 277
--experimental animals
---and humans: similar in tissue & intuition - 53R1-422
---practice sanitation by intuition-53R1-422
---practice autotherapy by intuition-53R1-422

GO TO REFERENCE LIST

--factors increasing liklihood of elective localization 27R9- 594
--failure of some autogenous vaccines, reason 39R1-32
--favorable result after both focus removed and vaccine 29R1- 510
--favorable results in 159/193 persons w/various diseases 58R1-760
--fermentative, morphological changes not uncommon; history.14R4
--filtered serum, opsonic properties (retained) 07R1-295
-- finding object in microscopic slide: 29R3
--focal exudate, localization of streptococci from 34R5-726
--Focal infection and elective localization [FI & EL]: 12R11, 14R1, 14R12, 15R1, 15R9, 17R5, 18R7, 19R3, 19R6, 21R6, 21R7, 23R8, 24R2, 27R4, 27R5, 28R1, 28R7, 29R1, 29R4, 30R2, 30R5, 30R6, 30R7, 30R10, 31R1, 31R3, 31R4, 34R5, 35R4, 35R6, 36R1, 37R1, 38R4, 39R1, 40R3, 42R2, 58R1
--foci removal may not cure disease, why 16R7-665, 29R1-504-5
--foci as test tubes with permeable walls 30R6-54
--foci: where bacteria acquire localizing power 23R8-211
-- Freeman; correlation with his toxin work 28R9-1407

GO TO REFERENCE LIST

--glycerin-salt reduces toxicity, preserves specificity 45R4- 163
--glycerin-salt storage menstrum necessary 37R1-254
--goals: serum therapy vs vaccine-therapy 12R11
--"green-producing" charactistic of S.rosenow 29R1-506

GO TO REFERENCE LIST

--heat: effect on leukocytes (lose phagocytic power) 06R1-687
--heat:effect on pneumococci to phagocytosis (no effect) 06R1
--heat:effect on serum opsonin for pneumococci (lessened) 06R1-686
--high frequency field changes virulence, etc. 50R1-123
-- high frequency radiation and cataphoresis change 33R7-497
-- High frequency radiation and seasonal change: 33R7, 35R3, 50R3
--histamine, effect on skin reactions 48R3-283
--Holman 1928, Rosenow's initial responses 28R10, 29R1-504
--humidifying patients' air: 27R6, 32R6

GO TO REFERENCE LIST

--IM or subcutaneous, antibody administration - 52R1-400, 52R3-309
--intramuscular therapeut. injections, improvement after 55R1-245
--intramuscular antiserum globulin concentrate,benefit 42R2- 351-2
--intramuscular injection, merits of 40R3
--intracerebral animal injections in nervous diseases 30R6-50
--invitro production of "antibody" from bacteria 45R4-163
--invitro antibody from gram-positive bacilli only 45R4-175
--isolation and production of streptococci - 58R1, 54R1
--keeping specimens frozen: 09R5, 14R10

GO TO REFERENCE LIST

--l-forms described by Rosenow in 1916 16R4-1202
--l-forms observed by Rosenow, per Science 42R1-100
--laboratory animal injection methods 29R1-505-6
--limitation of vaccine without removal of focus 34R5-721
- -limited benefit of focus removal 16R7-665
--list of nearly 50 disease conditions studied 53R1-415-8
- -locus minoris resistentiae, all pulpless teeth are 34R5-723-4
--locus minorus resistentiae & localization 16R7-665 (Meltzer SJ)
--low grade metabolism essential to seasonal change 50R3-292

GO TO REFERENCE LIST

--massage of subcutaneous vaccine site aids absorption 34R3-408
--methods 44R6-230
--Milk supplies and streptococci: 44R4
--mixed strains, broader localizing properties of 55R1-242
--mixtures of strains, remarkably increased virulence in 55R1-242
--mutation in streptococci, pneumococci, factors causing 30R6-37
--mutation/dissociation as factor in influenza 29R2-366
-- mutational changes, underlying conditions for 14R4-30
-- mutations as accounting for different diseases 39R1-28
-- mutations: nonhemolytic strept.<=>hemolytic 53R2-612
--mutations; confirming works cited 30R6-36

GO TO REFERENCE LIST

--nervous system diseases and streptococcal infection 48R1-124

GO TO REFERENCE LIST

--observ. of filter-passing organisms w/ Rife microscope: 32R5
--old chick cultures yield filtrable, virus-like forms 50R1-117
--opsonic index 14R4-10
--Oral/dental sepsis & elective localiz., etc.: 14R1, 17R5, 19R6, 21R7, 27R4, 27R5, 35R6, 36R1
--oral infection, harm through blood, not swallowing 19R6-243
--'ounce of prevention...' holds true 28R7-433
--oxygen gradients, importance of method affording- 14R12 thru 58R1
--oxygen tension, importance of variations in, citations 19R6-208

GO TO REFERENCE LIST

--parallel production: altered strepto. & filtrable agents - 51R3
--parallelism of results from different methods 42R2-353
-- pasteurization of milk requires 158 deg.F; 145 too low 51R4-616
--Pauling and Campbell, prior work on invitro antibody 45R4-163
--Pauling, Campbell & Pressman's work extended 47R1-231+
--penicillin nullifies benefits of therapeutic antibody 51R4-619
--pharmacological action of drug vs tropism of dead strepto-52R1
--physical characteristics affecting localization 30R1-49-50
--pneumococci made to look like staphylococci 14R4-18
--pneumonic leucocytes vs. normal; differences 06R1-688
-- polymorphic character of causative organism 15R4-382
--precipitation reactions for various diseases 42R2-342
-- proof of etiology is reproduction in animals 53R1-415
-- pulpless teeth must go; 8 supporting references 44R8-329
-- pulpless teeth, always extract regardless of x-ray 40R3-278
-- pulpless teeth are infected teeth 34R5
--pulpless teeth, symptomless, as foci 29R1-507
--pulpless teeth, hazard and incidence (80-90%) of 34R5-723
--pulpless teeth, the insoluble problem of apical ends 40R3-265

GO TO REFERENCE LIST

--radiant energy as cause of seasonality 50R1-123
--reactions of antibody/antigen injection, vs. histamine 48R2-368
--recurrence prone to occur unless focus removed 28R10-234
--relation between localization and cataphoretic time 40R3-274
--removal of foci as prophylaxis 34R5-739
--results of injections of streptococci from nasopharynx 55R1
--Rife microscope findings, polio filtrates 32R5-192
--Roentgenically negative teeth, infection in: 44R8
--root canals, failings of antiseptics in 34R5-724
--root canal therapy, devitalization "should cease" 30R6-56

GO TO REFERENCE LIST

--scavenger function of liver, kidney, spleen 55R1-242
--Seasonal change in streptococci: 33R6, 51R3
--seasonal change avoided with glycerin-NaCl storage 50R1-117
--seasonality of epidemics correlated with streptococci 33R6-11
--serial dilution method and high localizing power 40R3- 269
--serial dilution culture methodology 38R5-71, 44R1-151
-- Serologic specificity of streptocci & elective localiz.: 29R4
--similar organisms, different diseases -50R1, 58R1
--slowing action of immune serums on strept.34R2-116,122, 40R3-275
--solar radiant energy as agent of seasonality 50R3-292
-- solar radiant energy as streptococcus modifier 33R7-502
-- source of elective localizing property 40R3- 277
--special mediums for "really causative streptococci" 34R3-401
--specific serologic/antigenic reactions retained 15 yrs 34R3-407
--specificities as due to mutation or dissociation 53R2-613
--specificity determined by genetic predisposition 58R1-759
--specificity: ground level vs. mine vs. safe storage 50R3-291
--specificity preserved w/glycerin-NaCl storage 51R4-610, 48R2-371
--spread of virulent streptococci in air; in water - 51R3,45R7
--staphylococcus phages, serial dilution cultures 38R5
--streptococci: affinity for specific tissue 14R12-906
--streptococci as source of toxins in epilepsy and schizo.-53R1
--streptococci with affinity for source organs 15R9-1688
--streptococci from "almost unbelievably high dilution" 40R3-269
--streptococci in air, milk, water and epidemic victims 53R2-610
--streptococci: pneumotropic in winter vs neurotropic, summer 50R3
--streptococcus in urine, muscles, ovaries, spinal fluid 53R1-418
--Streptococcus rosenow defined 34R2-92
--streptococcus vs. virus in common cold, influenza - 45R5, 44R3, 53R2, 38R2-17, 34R3-403
--streptococcus with no name 34R5-741
--subcutaneous or IM, antibody administration - 52R1-400, 52R3-309
--submicroscopic forms develop in chick embryo medium - 50R1
--summary of six types of evidence of etiology 40R3- 277
-- symptomless foci, importance of 29R1-506, 30R6-55, 34R5-722
-- symptomless teeth as focus 30R6-29

GO TO REFERENCE LIST

--technic for isolating streptococcus 39R1-36, 48R5-486
-- teeth, never extract vital teeth 19R6-246, 40R3-278
--teeth, symptomless pulpless: see "pulpless teeth"
--thermal agglutinins support concept of heat therapy 45R4-178
--thermal antibody, explanation of designation of 58R1-756
--time of reactions to antibody (immed.), antigen (slow) 48R2-368
--tonsils as foci of various systemic diseases 30R6-53
--tonsils, elective localization of bacteria from pus in 19R6-215
--tonsils,infected, test tubes for circulating pathogens 16R7-666
--tonsils, need to remove if no other focus is found 34R5-740
--tonsils, remnants of, as foci 29R1-507
--tonsils, removal is illogical if teeth are infected 40R3-262
--toxic bacterial components, destruction w/heat,H2O2 47R1-229
--toxic material from bacteria: 09R9
--toxicity:vaccines from glycerin-salt solution are less 42R2-352
--toxicity vs. antigenicity (inverse relation)10R3-1943,16R1- 1929
--Transmutation - streptococi and pneumococci: 13R2, 14R4, 14R6
--Transformation - bacteria from virus & phage by serial dilution method: 38R5
--Transformation - filtrable agent from streptococcus - 44R1
--trauma or exposure, ill effect due to lack of oxygen 15R9- 1690
--tropism of dead streptococci vs action of drugs-52R1-398

GO TO REFERENCE LIST

--vaccine and serum therapy 33R3-182-4
--vaccine and serum-vaccine preparation 37R5-828
--vaccine dosage - warning against too-large 29R1-511
--vaccine dose, prophylactic inoculation 34R3-408
--vaccine preparation, dosage 30R6-33, 29R1-506, 34R3-406-9
--vaccine preparation, administration, for colds, influenza
--Beneficial results of vaccines for cold/influenza -38R2-20
--Vaccine prep. summary (Colds/Influenza) - 55R2, 38R2-19
--Vaccine prep. detail, etc (Colds/Influenza) - 34R3-408
--Vaccines & elective localiz., etc.: 12R11, 19R3, 29R1, 42R2
--vaccines benefit 80-90% cold, influenza, pneumonia, etc.34R3-419
--vaccine-therapy results 12R11-77-80
--Valentine and Van Meter, point overlooked by 40R3-268-9
--velocity of migration varies with surface charge 40R3-274
--viability of streptococci w/out transfer for 22 years 50R1- 120
--viridans streptococci, proof of etiologic role 29R1-510
- -virulence changes in chick embryo medium - 50R1
--virulence decreases on artificial media 30R6-37
--virulence increases remarkably in mixed cultures - 55R1-246
--virulence increases with animal passage 30R6-37
--virulence manipulated with radiant energy 50R3-290
--virulence of streptococci reflect severity of epidemics 53R2-610
--virulence vs. charge, lack of correlation between 30R1-51
--virulent bacteria grow in far higher dilutions 48R3-272
- -virulent, nonvirulent streptococci indistinguishable 53R2-612
--virulent outgrow nonvirulent strept. in young cultures 53R2-612
--virulent pneumococci not susceptible to phagocytosis 08R2-15
--virulent pneumococci neutralize opsonin in serum 08R1-657
--virulin 08R1-658, 08R2-15
--virus compared to filtrable agent -54R1, 52R3, 53R2, 45R6
--virus vs streptococcus 38R5-70, 42R2, 44R6-260, 53R1-424, 53R2-620

GO TO REFERENCE LIST

--Water supplies and streptococci: 45R7
--water, seasonally virulent streptococci in 50R1-122
--Wright and Douglas, augments work of; opsonins 06R1- 686

GO TO REFERENCE LIST